Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Sotio Biotech Inc.
Ocellaris Pharma, Inc.
Blueprint Medicines Corporation
Actym Therapeutics, Inc.
NiKang Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
Pfizer
NuCana plc
University of Virginia
Telix Pharmaceuticals (Innovations) Pty Limited
Pfizer
Black Diamond Therapeutics, Inc.
Kymab Limited
Mayo Clinic
Seagen Inc.
Seagen Inc.
Seagen Inc.
Aminex Therapeutics, Inc.
Rain Oncology Inc
Johns Hopkins University
NextCure, Inc.
ADC Therapeutics S.A.
Laval University
University of Florida
Fusion Pharmaceuticals Inc.
pharmaand GmbH
Fate Therapeutics
Fate Therapeutics
Incyte Corporation
Zai Lab (Hong Kong), Ltd.
ExcellaBio LLC
Incyte Corporation
Seagen Inc.
KitovPharma
AIDS Malignancy Consortium
M.D. Anderson Cancer Center
UMC Utrecht
CureOne
National Institutes of Health Clinical Center (CC)
University Hospital Tuebingen
Universitätsmedizin Mannheim
SWOG Cancer Research Network
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
New Mexico Cancer Research Alliance
National Cancer Institute (NCI)
Cancer Research UK